Antisoma to raise 8.7 million

Antisoma (LSE:ASM; EASD:ASOM), a cancer drug development company, said it plans to raise 8.7 million ($13.1 million) through a placing of 7.7 million shares at 117p a share. Nomura is the broker. ...